Zobrazeno 1 - 10
of 132
pro vyhledávání: '"Frenel JS"'
Publikováno v:
Cancer Management and Research, Vol Volume 11, Pp 4297-4312 (2019)
Pauline du Rusquec, Ombline de Calbiac, Marie Robert, Mario Campone, Jean Sebastien FrenelMedical Oncology Department, Institut de Cancérologie de l’Ouest, Saint-Herblain 44800, FranceAbstract: Pembrolizumab is a full-length human immunoglobulin G
Externí odkaz:
https://doaj.org/article/b5c0c41201ed45adbe8f22e6edcd02fa
Autor:
Blanc-Lapierre, A., Delacour, S., Duval, M., Ayrault-Piault, S., Frenel, JS., CowppliBony, A., Monilié, F.
Publikováno v:
Journal of Epidemiology and Population Health; May 2024, Vol. 72 Issue: 1, Number 1 Supplement 2
Publikováno v:
Expert Review of Anticancer Therapy; Feb2012, Vol. 12 Issue 2, p195-201, 7p
Autor:
Roth P; Department of Neurology and Brain Tumor Center, University Hospital Zurich, Zurich, Switzerland.; Department of Neurology, University of Zurich, Zurich, Switzerland., Gorlia T; European Organisation for Research and Treatment of Cancer (EORTC), Brussels, Belgium., Reijneveld JC; Department of Neurology & Brain Tumor Center, Amsterdam University Medical Centers, Amsterdam, The Netherlands., de Vos F; Department of Medical Oncology, University Medical Center Utrecht, University Utrecht, Utrecht, The Netherlands., Idbaih A; Sorbonne Université, AP-HP, Institut du Cerveau - Paris Brain Institute - ICM, Inserm, CNRS, Hôpitaux Universitaires La Pitié Salpêtrière - Charles Foix, DMU Neurosciences, Service de Neurologie 2-Mazarin, Paris, France., Frenel JS; Department of Medical Oncology, Institut de Cancerologie de L'Ouest, Saint-Herblain, France., Le Rhun E; CHU Lille, Service de neurochirurgie, Lille, France.; Univ. Lille, Inserm, CHU Lille, U1192, Laboratoire Protéomique, Réponse Inflammatoire et Spectrométrie de Masse (PRISM), Lille, France.; Department of Neurosurgery & Clinical Neuroscience Center, University Hospital and University of Zurich, Zurich, Switzerland., Sepulveda JM; Neuro-Oncology Unit, Department of Medical Oncology, Instituto de Investigación Hospital 12 de Octubre, Madrid, Spain., Perry J; Division of Neurology, Sunnybrook HSC, University of Toronto, Toronto, Ontario, Canada., Masucci GL; Department of Radiation Oncology, Centre Hospitalier de l'Université de Montréal (CHUM), Montréal, Québec, Canada., Freres P; Department of Medical Oncology, University Hospital of Liege, Liege, Belgium., Hirte H; Department of Oncology, McMaster University, Hamilton, Ontario, Canada., Seidel C; Department of Radiation Oncology, University Hospital Leipzig, Leipzig, Germany., Walenkamp A; Department of Medical Oncology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands., Lukacova S; Department of Oncology, Aarhus University Hospital, Aarhus, Denmark., Meijnders P; Department of Radiation Oncology, Iridium Network Antwerpen, University of Antwerp, Antwerp, Belgium., Blais A; Service d'hématologie et d'oncologie, Centre intégré de cancérologie du CHU de Québec - Université Laval, Québec City, Québec, Canada., Ducray F; Department of Neuro-Oncology, Hospices Civils de Lyon and Université Claude Bernard Lyon 1, Lyon, France.; Lyon Cancer Research Center (CRCL) UMR INSERM 1052 CNRS 5286, Lyon, France., Verschaeve V; Department of Medical Oncology, GHDC Grand Hopital de Charleroi, Charleroi, Belgium., Nicholas G; University of Ottawa, Division of Medical Oncology, Ottawa, Ontario, Canada., Balana C; Badalona Applied Research Group in Oncology (B-ARGO Group), Institut Investigació Germans Trias i Pujol (IGTP), Badalona, Spain., Bota DA; Chao Family Comprehensive Cancer Center and Department of Neurology, University of California, Irvine, California, USA., Preusser M; Division of Oncology, Department of Medicine I, Medical University of Vienna, Vienna, Austria., Nuyens S; European Organisation for Research and Treatment of Cancer (EORTC), Brussels, Belgium., Dhermain F; Department of Radiation Oncology, University Hospital Gustave Roussy, Villejuif, France., van den Bent M; Brain Tumor Center at ErasmusMC Cancer Institute, Rotterdam, The Netherlands., O'Callaghan CJ; Canadian Cancer Trials Group, Queen's University, Kingston, Ontario, Canada., Vanlancker M; European Organisation for Research and Treatment of Cancer (EORTC), Brussels, Belgium.; Princess Margaret Cancer Centre, Toronto, Ontario, Canada., Mason W; Department of Medicine, Princess Margaret Cancer Centre, University of Toronto, Toronto, Ontario, Canada., Weller M; Department of Neurology and Brain Tumor Center, University Hospital Zurich, Zurich, Switzerland.; Department of Neurology, University of Zurich, Zurich, Switzerland.
Publikováno v:
Neuro-oncology [Neuro Oncol] 2024 Sep 05; Vol. 26 (9), pp. 1670-1682.
Autor:
Xu-Vuillard A; Medical Oncology Department, Gustave Roussy, Villejuif; Sorbonne Université, Paris., Guerin-Charbonnel C; Department of Biostatistics and Analytics, Institut de Cancérologie de L'Ouest, Nantes., Bocquet F; Data Factory, Institut de Cancérologie de L'ouest, Nantes, France., Cheeseman S; Leeds Cancer Center, Leeds Teaching Hospitals NHS Trust, Leeds, UK., Kubelac PM; The Oncology Institute Prof. Dr Ion Chiricuta, Kluj-Napoca, Romania., Zenatri M; Medical Oncology Department, Institut de Cancérologie de L'Ouest, Saint-Herblain., Hall G; Leeds Cancer Center, Leeds Teaching Hospitals NHS Trust, Leeds, UK., Achimas-Cadariu P; The Oncology Institute Prof. Dr Ion Chiricuta, Kluj-Napoca, Romania; Medical Oncology Department, Institut de Cancérologie de L'Ouest, Saint-Herblain; Medical Oncology Department, Centre Leon Berard, Lyon, France; Oncology Evidence Network, IQVIA, London, UK; City Hospital, Timisoara, Romania; Medical Oncology Department, Institut de Cancérologie de L'Ouest, Angers, France; University of Medicine and Pharmacy Iuliu Hatieganu, Kluj-Napoca, Romania., Hanvic B; Medical Oncology Department, Centre Leon Berard, Lyon, France., Fenton H; Oncology Evidence Network, IQVIA, London, UK., Sturz-Lazăr AM; City Hospital, Timisoara, Romania., Augereau P; Medical Oncology Department, Institut de Cancérologie de L'Ouest, Angers, France., Ray-Coquard I; Medical Oncology Department, Centre Leon Berard, Lyon, France., Leary A; Medical Oncology Department, Gustave Roussy, Villejuif., Frenel JS; Medical Oncology Department, Institut de Cancérologie de L'Ouest, Saint-Herblain. Electronic address: jean-sebastien.frenel@ico.unicancer.fr.
Publikováno v:
ESMO open [ESMO Open] 2024 Sep; Vol. 9 (9), pp. 103694. Date of Electronic Publication: 2024 Sep 03.
Autor:
Jézéquel P; Institut de Cancérologie de l'Ouest, 44805, Saint Herblain, France. pascal.jezequel@ico.unicancer.fr.; Nantes Université, Univ Angers, INSERM, CNRS, CRCI2NA, 44000, Nantes, France. pascal.jezequel@ico.unicancer.fr.; Équipe Labellisée LIGUE Contre Le Cancer CRCI2NA, 44000, Nantes, France. pascal.jezequel@ico.unicancer.fr., Lasla H; Institut de Cancérologie de l'Ouest, 44805, Saint Herblain, France., Gouraud W; Institut de Cancérologie de l'Ouest, 44805, Saint Herblain, France., Basseville A; Institut de Cancérologie de l'Ouest, 44805, Saint Herblain, France., Michel B; Nantes Université, École Centrale Nantes, CNRS, Laboratoire de Mathématiques Jean Leray, LMJL, UMR 6629, 44000, Nantes, France., Frenel JS; Institut de Cancérologie de l'Ouest, 44805, Saint Herblain, France.; Nantes Université, Univ Angers, INSERM, CNRS, CRCI2NA, 44000, Nantes, France.; Équipe Labellisée LIGUE Contre Le Cancer CRCI2NA, 44000, Nantes, France., Juin PP; Nantes Université, Univ Angers, INSERM, CNRS, CRCI2NA, 44000, Nantes, France.; Équipe Labellisée LIGUE Contre Le Cancer CRCI2NA, 44000, Nantes, France., Ben Azzouz F; Institut de Cancérologie de l'Ouest, 44805, Saint Herblain, France., Campone M; Institut de Cancérologie de l'Ouest, 44805, Saint Herblain, France.; Nantes Université, Univ Angers, INSERM, CNRS, CRCI2NA, 44000, Nantes, France.; Équipe Labellisée LIGUE Contre Le Cancer CRCI2NA, 44000, Nantes, France.; Université d'Angers, 49000, Angers, France.
Publikováno v:
Breast cancer (Tokyo, Japan) [Breast Cancer] 2024 Sep; Vol. 31 (5), pp. 825-840. Date of Electronic Publication: 2024 May 22.
Autor:
Poumeaud F; Department of Medical Oncology, Oncopole Claudius Regaud, IUCT-O, Toulouse, France. poumeaud.francois@iuct-oncopole.fr., Morisseau M; Biostatistics & Health Data Science Unit, Oncopole Claudius Regaud IUCT-O, Toulouse, France., Cabel L; Department of Medical Oncology, Institut Curie, Paris, France., Gonçalves A; Aix-Marseille University, CNRS, INSERM, Institut Paoli-Calmettes, Department of Medical Oncology, CRCM, Marseille, France., Rivier C; Department of Medical Oncology, Centre Léon Bérard, Cancer Research Center of Lyon (UMR Inserm 1052 - CNRS 5286), Lyon, France., Trédan O; Department of Medical Oncology, Centre Léon Bérard, Cancer Research Center of Lyon (UMR Inserm 1052 - CNRS 5286), Lyon, France., Volant E; Department of Medical Oncology, Institut de cancérologie de l'Ouest, Saint-Herblain, France., Frenel JS; Department of Medical Oncology, Institut de cancérologie de l'Ouest, Saint-Herblain, France., Ladoire S; Department of Medical Oncology, Centre Georges-François Leclerc, INSERM U1231, Dijon, France., Jacot W; Department of Medical Oncology, Institut du Cancer de Montpellier, Montpellier University, INSERM U1194, Montpellier, France., Jamelot M; Department of Medical Oncology and Cellular Therapy, Faculté de médecine Sorbonne Université, Hôpital Tenon, Paris, France., Foka Tichoue H; Department of Medical Oncology, Hôpital de la Pitié-Salpêtrière, Institut Universitaire de Cancérologie AP-HP, Sorbonne Université, Paris, France., Patsouris A; Department of Medical Oncology, Institut de Cancérologie de l'Ouest Pays de la Loire, Angers, France., Teixeira L; Department of Medical Oncology, INSERM U976, Université de Paris Cité, Hopital Saint Louis, Paris, France., Bidard FC; Department of Medical Oncology, Institut Curie, Saint-Cloud, France.; Versailles Saint-Quentin University, Paris Saclay, Saint-Cloud, France., Loirat D; Department of Medical Oncology, Institut Curie, Paris, France., Brunet M; Clinical Trials Department - Breast Cancers, Institut Bergonié, Bordeaux, France., Levy C; Department of Medical Oncology, Centre François Baclesse, Caen, France., Bailleux C; Department of Medical Oncology, Centre Antoine Lacassagne, Nice, France., Cabarrou B; Biostatistics & Health Data Science Unit, Oncopole Claudius Regaud IUCT-O, Toulouse, France., Deleuze A; Department of Medical Oncology, Centre Eugène Marquis, Rennes, France., Uwer L; Department of Medical Oncology, Institut de Cancérologie de Lorraine, Nancy, France., Deluche E; Department of Medical Oncology, Centre Hospitalier Universitaire de Limoges, Limoges, France., Grellety T; Department of Medical Oncology, Centre Hospitalier de la côte basque, Bayonne, France., Franchet C; Department of Pathology, Oncopole Claudius Regaud, IUCT-O, Toulouse, France., Fiteni F; Department of Medical Oncology, University Hospital, Nimes, France.; UMR INSERM IDESP-Desbrest Institute of Epidemiology and Public Health, University of Montpellier, Montpellier, France., Bischoff H; Department of Medical Oncology, Institut de Cancérologie de Strasbourg Europe, Strasbourg, France., Vion R; Department of Medical Oncology, Centre Henri Becquerel, Rouen, France., Pagliuca M; University Paris-Saclay, Gustave Roussy, INSERM U981, Molecular Predictors and New Targets in Oncology, Villejuif, France.; Division of Breast Medical Oncology, Instituto Nazionale Tumori - IRCCS - Fondazione G. Pascale, Napoli, Italia., Verret B; Departmentof Medical Oncology, Institut Gustave Roussy, Paris, France., Bécourt S; Department of Medical Oncology, Centre Oscar Lambret, Lille, France., Reverdy T; Department of Medical Oncology, Institut de Cancérologie des Hospices Civils de Lyon (IC-HCL), Université Lyon 1, Lyon, France., de Nonneville A; Aix-Marseille University, CNRS, INSERM, Institut Paoli-Calmettes, Department of Medical Oncology, CRCM, Marseille, France., Dalenc F; Department of Medical Oncology, Oncopole Claudius Regaud, IUCT-O, Toulouse, France.
Publikováno v:
British journal of cancer [Br J Cancer] 2024 Sep; Vol. 131 (4), pp. 702-708. Date of Electronic Publication: 2024 Jun 25.
Autor:
Kabirian R; Department of Medical Oncology, Gustave Roussy, Villejuif, & GINECO, France., Tredan O; Centre Léon Bérard, Lyon, & GINECO, France., Marmé F; Medical Faculty Mannheim, Heidelberg University & AGO Study Group, Germany., Paoletti X; Biostatistic Unit, Institut Curie, Paris, France., Eberst L; Institut de Cancérologie de Strasbourg Europe, ICANS, Strasbourg, & GINECO, France., Lebreton C; Institut Bergonié, Bordeaux, & GINECO, France., La Motte Rouge T; Centre Eugène Marquis, Rennes, & GINECO, France., Sabatier R; Aix-Marseille Univ, CRCM, Inserm, CNRS, Institut Paoli-Calmettes, Department of Medical Oncology, Marseille, & GINECO, France., Angelergues A; Groupe Hospitalier Diaconesses-Croix Saint-Simon, Paris, & GINECO, France., Fabbro M; Institut du Cancer de Montpellier (ICM), Montpellier, & GINECO, France., Gorp TV; Leuven Cancer Institute, Division of Gynaecological Oncology, University Hospital Leuven, BGOG,Belgium., Mansi L; CHU Besançon - Hôpital jean Minjoz, Besançon, & GINECO, France., Gladieff L; Oncopole Claudius Regaud, IUCT-Oncopole, Toulouse, & GINECO, France., Kaczmarek E; Centre Oscar Lambret, Lille, & GINECO, France., Alexandre J; Université de Paris Cité, AP-HP, Hôpital Cochin, Paris, & GINECO, France., Grellety T; Centre Hospitalier de la Côte Basque, Bayonne, & GINECO, France., Favier L; Centre Georges François Leclerc, Dijon, & GINECO, France., Welz J; Evang. Kliniken Essen-Mitte - ESSEN & AGO Study Group, Germany., Frenel JS; Institut de Cancérologie de l'Ouest, Centre René Gauducheau, 44800, Saint Herblain, & GINECO,France., Leary A; Department of Medical Oncology, Gustave Roussy, Villejuif, & GINECO, France.
Publikováno v:
Future oncology (London, England) [Future Oncol] 2024 Aug 19, pp. 1-10. Date of Electronic Publication: 2024 Aug 19.
Autor:
Zenatri M; Department of Medical Oncology, Institut de Cancerologie de l'Ouest, Centre René Gauducheau, Saint-Herblain, France., Perennec T; Radiation Oncology Department, Institut de Cancerologie de l'Ouest, Centre René Gauducheau, Saint-Herblain, France., Michon C; Department of Biopathology, Institut de Cancerologie de l'Ouest, Centre Paul Papin, Angers, France., Gernier F; Clinical Research Department, Centre Francois Baclesse, Caen, France., Grellard JM; Clinical Research Department, Centre Francois Baclesse, Caen, France., Piloquet FX; Department of Medical Oncology, Institut de Cancerologie de l'Ouest, Centre René Gauducheau, Saint-Herblain, France., Dubot-Poitelon C; Medical Oncology Department, Centre Francois Baclesse, Unicaen University, Caen, France., Kalbacher E; Oncology Department, CHRU Besancon - Hopital Jean Minjoz, Besancon, France., Tredan O; Medical Oncology, Centre Léon Bérard, Lyon, France., Augereau P; Medical Oncology Department, Institut de Cancerologie de l'Ouest, Centre Paul Papin, Angers, France., Pautier P; Medicine Department, Institut Gustave Roussy, Villejuif, France., Fey L; Department of Biopathology, Institut de Cancerologie de l'Ouest, Centre Paul Papin, Angers, France., Joly F; Medical Oncology Department, Centre Francois Baclesse, Unicaen University, Caen, France., Frenel JS; Medical Oncology Department, Institut de Cancerologie de l'Ouest, Centre Rene Gauducheau, GINECO Group and GINEGEPS, Saint-Herblain, France. Electronic address: jean-sebastien.frenel@ico.unicancer.fr.
Publikováno v:
Gynecologic oncology [Gynecol Oncol] 2024 Aug; Vol. 187, pp. 139-144. Date of Electronic Publication: 2024 May 21.
Autor:
Aubert M; Department of Medical Oncology, CHU Bretonneau Tours, Tours, France., Mathiot L; Department of Medical Oncology, Institut de Cancérologie de l'Ouest, Site René Gauducheau, Saint Herblain, France., Vegas H; Department of Medical Oncology, CHU Bretonneau Tours, Tours, France., Ouldamer L; Department of Gynecology, CHU Bretonneau Tours, Tours, France., Linassier C; Department of Medical Oncology, CHU Bretonneau Tours, Tours, France., Augereau P; Department of Medical Oncology, Institut de Cancérologie de l'Ouest, Site Paul Papin, Angers, France., Bocquet F; Data Factory and Analytics, Institut de Cancérologie de l'Ouest, Site René Gauducheau, Saint Herblain, France., Frenel JS; Department of Medical Oncology, Institut de Cancérologie de l'Ouest, Site René Gauducheau, Saint Herblain, France., Cancel M; Department of Medical Oncology, CHU Bretonneau Tours, Tours, France.
Publikováno v:
The oncologist [Oncologist] 2024 Jul 05; Vol. 29 (7), pp. e910-e917.